Stock Scorecard



Stock Summary for scPharmaceuticals Inc (SCPH) - $5.03 as of 3/28/2024 11:53:29 AM EST

Total Score

7 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SCPH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SCPH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SCPH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for SCPH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for SCPH

Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight 1/24/2024 10:01:00 PM
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight 1/15/2024 10:05:00 PM
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) 10/5/2023 12:00:00 PM
ScPharmaceuticals, Inc. ( SCPH ) Reports Q2 Loss, Tops Revenue Estimates 8/10/2023 9:40:00 PM
scPharmaceuticals, Inc. ( SCPH ) Loses -21.78% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner 7/18/2023 1:35:00 PM
Short Interest Sector Focus: Healthcare Sector - Novavax ( NASDAQ:NVAX ) 6/29/2023 4:56:00 PM
Short Interest Sector Focus: Healthcare Sector - Novavax ( NASDAQ:NVAX ) 6/28/2023 2:24:00 PM
scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes 6/23/2023 12:00:00 PM
scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes - scPharmaceuticals ( NASDAQ:SCPH ) 6/23/2023 12:00:00 PM
scPharmaceuticals to Present at the Jefferies Healthcare Conference 5/31/2023 12:00:00 PM

Financial Details for SCPH

Company Overview

Ticker SCPH
Company Name scPharmaceuticals Inc
Country USA
Description scPharmaceuticals Inc., a pharmaceutical company, is engaged in the development and commercialization of various pharmaceutical products. The company is headquartered in Burlington, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 5.03
Last Day Price Updated 3/28/2024 11:53:29 AM EST
Last Day Volume 229,540
Average Daily Volume 247,476
52-Week High 12.75
52-Week Low 4.63
Last Price to 52 Week Low 8.64%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -4.40
Free Cash Flow Ratio 2.38
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 7.08
Total Cash Per Share 2.11
Book Value Per Share Most Recent Quarter 1.03
Price to Book Ratio 4.71
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 12.89
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 36,054,400
Market Capitalization 181,353,632
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -48.79%
Reported EPS 12 Trailing Months -1.42
Reported EPS Past Year -1.42
Reported EPS Prior Year -1.30
Net Income Twelve Trailing Months -54,810,000
Net Income Past Year -54,810,000
Net Income Prior Year -36,838,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 76,013,000
Total Cash Past Year 76,013,000
Total Cash Prior Year 118,186,000
Net Cash Position Most Recent Quarter 37,202,000
Net Cash Position Past Year 37,202,000
Long Term Debt Past Year 38,811,000
Long Term Debt Prior Year 36,794,000
Total Debt Most Recent Quarter 38,811,000
Equity to Debt Ratio Past Year 0.49
Equity to Debt Ratio Most Recent Quarter 0.49
Total Stockholder Equity Past Year 37,218,000
Total Stockholder Equity Prior Year 72,433,000
Total Stockholder Equity Most Recent Quarter 37,218,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.04
MACD Signal -0.01
20-Day Bollinger Lower Band 4.82
20-Day Bollinger Middle Band 5.65
20-Day Bollinger Upper Band 6.48
Beta 0.07
RSI 50.05
50-Day SMA 7.46
200-Day SMA 6.60

System

Modified 3/27/2024 6:16:03 AM EST